Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

NCT00437359 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Toremifene citrate
DRUG: Anastrozole

Sponsor

Japan Breast Cancer Research Network